$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색도움말
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"

통합검색

도움말도움말
상세검색 다국어 입력

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

특허 상세정보

MyON담기
내보내기 페이스북 공유 카카오톡 공유

Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)

특허상세정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판) A61K-009/22    A61K-009/56    A61M-037/00   
미국특허분류(USC) 424/424 ; 424/426 ; 424/427 ; 424/433 ; 424/436 ; 424/484 ; 424/486
출원번호 US-0544808 (1975-01-28)
발명자 / 주소
출원인 / 주소
대리인 / 주소
    Sabatine, Paul L.Ciotti, Thomas E.Mandell, Edward L.
인용정보 피인용 횟수 : 274  인용 특허 : 3
초록
▼

The invention concerns orthoester and orthocarbonate polymers having a repeating mer comprising a hydrocarbon radical and a symmetrical dioxycarbon unit of the general formula: ##STR1## WHEREIN R.sub.1 is a multivalent hydrocarbon radical, R.sub.2 and R.sub.3 are hydrocarbon radicals with at least one of R.sub.2 or R.sub.3 bonded to the dioxycarbon through an oxygen linkage, and which polymers are synthesized by reacting a polyol with an orthoester or orthocarbonate. The polymers are useful for making articles of manufacture, including devices and coatin...

대표청구항이 없습니다

이 특허에 인용된 특허 (3)

  1. Hussain Anwar A. (Lexington KY) Higuchi Takeru (Lawrence KS) Shell John W. (Los Altos CA). Bioerodible ocular device. USP1976063960150.
  2. Heller Jorge (Palo Alto CA) Baker Richard W. (Bend OR). Device for delivery of useful agent. USP1977034014987.
  3. Shell John W. (Los Altos CA). Ophthalmological bioerodible drug dispensing formulation. USP1977014001388.

이 특허를 인용한 특허 피인용횟수: 274

  1. Himmelstein Kenneth J. (Lawrence KS) Higuchi Takeru (Lawrence KS). Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances d. USP1984124489056.
  2. Gallop, Mark A.. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use. USP2009077566738.
  3. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A.. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use. USP2010087777070.
  4. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A.. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use. USP2009097592369.
  5. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A.. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use. USP2013028372881.
  6. Zerangue,Noa; Jandeleit,Bernd; Li,Yunxiao; Gallop,Mark A.. Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use. USP2008047351740.
  7. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use. USP2010077749985.
  8. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use. USP2009097585996.
  9. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use. USP2018049944592.
  10. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use. USP2009087572830.
  11. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use. USP2006097109239.
  12. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use. USP2007117300956.
  13. Gallop,Mark A.. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use. USP2009027494985.
  14. Gallop, Mark; Cundy, Kenneth C.; Scheuerman, Randall A.; Barrett, Ronald W.; Zerangue, Noa. Amino acid conjugates providing for sustained systemic concentrations of GABA analogues. USP2010017645797.
  15. Gallop,Mark; Cundy,Kenneth C.; Scheuerman,Randall A.; Barrett,Ronald W.; Zerangue,Noa. Amino acid conjugates providing for sustained systemic concentrations of GABA analogues. USP2008097420002.
  16. Alster, Yair; de Juan, Jr., Eugene; Reich, Cary J.; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Macfarlane, K. Angela; Sutton, Douglas. Anterior segment drug delivery. USP2016089421126.
  17. Alster, Yair; de Juan, Jr., Eugene; Reich, Cary J.; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Macfarlane, K. Angela; Sutton, Douglas. Anterior segment drug delivery. USP20180610004636.
  18. Hobot, Christopher M.; Benz, Michael E.; Hildebrand, Keith R.; Pudil, Bryant J.. Baclofen formulation in a polyorthoester carrier. USP2013078475823.
  19. Hobot, Christopher M.; Benz, Michael E.; Hildebrand, Keith R.; Pudil, Bryant J.. Benzodiazepine formulation in a polyorthoester carrier. USP2015018940315.
  20. Fuisz Richard C. (Great Falls VA). Biodegradable controlled release flash flow melt-spun delivery system. USP1996055518730.
  21. Bader Hubert (Mainz DEX) Rppel Diether (Frankfurt am Main DEX) Walch Axel (Frankfurt am Main DEX). Biodegradable poly(hydroxyalkyl)amino dicarboxylic acid) derivatives, a process for their preparation, and the use there. USP1990034906473.
  22. Berde Charles B. (Brookline MA) Langer Robert S. (Newton MA). Biodegradable polymer matrices for sustained delivery of local anesthetic agents. USP1997045618563.
  23. Berde Charles B. ; Langer Robert S.. Biodegradable polymer matrices for sustained delivery of local anesthetic agents. USP2001046214387.
  24. Shih Chung ; Zentner Gaylen M. ; Sparer Randall V. ; Seward R. Lee. Bioerodible implants. USP1998115837228.
  25. Ng, Steven Y.; Heller, Jorge. Bioerodible poly (orthoesters) from dioxolane-based diketene acetals. USP2004116822000.
  26. Heller,Jorge; Ng,Steven Y.. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them. USP2006057045589.
  27. Ng, Steven Y.; Heller, Jorge. Bioerodible polyorthoesters containing amine groups. USP2003026524606.
  28. Ng, Steven Y.; Heller, Jorge. Bioerodible polyorthoesters from dioxolane-based diketene acetals. USP2003076590059.
  29. Bader Hubert (Mainz DEX) Rppel Diether (Frankfurt am Main DEX) Walch Axel (Frankfurt am Main DEX) Magerstdt Michael (Liederbach DEX). Biologically degradable polyamide for depot preparations having controlled release of the active compound. USP1989054835248.
  30. Ng, Steven Y.; Heller, Jorge. Block copolymers based on poly(ortho esters) containing amine groups. USP2003126667371.
  31. Ng, Steven Y.; Heller, Jorge. Block copolymers based on poly(ortho esters) containing amine groups. USP2005096946145.
  32. Hobot, Christopher M.; Benz, Michael E.; Hildebrand, Keith R.; Pudil, Bryant J.. Bupivacaine formulation in a polyorthoester carrier. USP2015028956642.
  33. Xiang,Jia Ning; Gallop,Mark A.; Cundy,Kenneth C.; Li,Jianhua; Xu,Feng; Zhou,Cindy X.; Bhat,Laxminarayan. Carbidopa prodrugs and derivatives, and compositions and uses thereof. USP2006097101912.
  34. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q.. Catechol protected levodopa diester prodrugs, compositions, and methods of use. USP2010117829592.
  35. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q.. Catechol protected levodopa diester prodrugs, compositions, and methods of use. USP2012128324273.
  36. Pacetti, Stephen D.; Hossainy, Syed F. A.; Tang, Yiwen; Tung, Andrew C.; Glauser, Thierry. Coatings for drug delivery devices having gradient of hydration. USP2012078231962.
  37. Devlin, Brid; Holt, Jonathon Daryll; Brimer, Andrew Nathan; Nuttall, Jeremy Peter; Malcolm, Karl; Fetherston, Susan Margaret; Boyd, Peter John James. Combination therapy intravaginal rings. USP20181110137031.
  38. Choi Nam S. (Seoul KRX). Composition comprising useful agent such as fertilizers, housed in heterocyclic polymer. USP1981034259102.
  39. Stanley Theodore H. (Salt Lake City UT) Hague Brian (West Valley UT). Compositions and methods of manufacture of compressed powder medicaments. USP1989094863737.
  40. Ottoboni, Thomas B.; Schillinger, Lee Ann Lynn. Compositions of a polyorthoester and an aprotic solvent. USP2017039592227.
  41. Ottoboni, Thomas B.; Schillinger, Lee Ann Lynn. Compositions of a polyorthoester and an aprotic solvent. USP2018039913909.
  42. Ottoboni, Thomas B.; Schillinger, Lee Ann Lynn; Niemann, Joseph. Compositions of a polyorthoester and an aprotic solvent. USP2017089744163.
  43. Ottoboni, Thomas B.; Schillinger, Lee Ann Lynn; Niemann, Joseph. Compositions of a polyorthoester and an aprotic solvent. USP2016099446036.
  44. Brem Henny ; Langer Robert S. ; Domb Abraham J.,ILX. Controlled local delivery of chemotherapeutic agents for treating solid tumors. USP200110RE37410.
  45. Brocchini,Stephen J.; Heller,Jorge; Tomlinson,Ryan; Duncan,Ruth; Garrett,Shane; Klee,Marcus M.. Degradable polyacetal polymers. USP2007057220414.
  46. Edwards, Jeffrey D.. Delivery of oral care products. USP2016099452037.
  47. Edwards, Jeffrey D.. Delivery of skin care products. USP2016109463330.
  48. Rossello, Armando; Nuti, Elisa; Avramova, Stanislava Ivanova; Uggeri, Fulvio; Maiocchi, Alessandro. Diagnostic agents selective against metalloproteases. USP2016119480758.
  49. Gupta Suneel K. ; Guinta Diane R. ; Christopher Carol A. ; Saks Samuel R.. Dosage form and method for administering drug. USP2000036034101.
  50. Ayer Atul D. ; Lam Andrew ; Magruder Judy A. ; Hamel Lawrence G. ; Wong Patrick S. L.. Dosage form, process of making and using same. USP2000086096339.
  51. Schmitt Edward E. (Palo Alto CA). Drug delivery devices comprising erodible polymer and erosion rate modifier. USP1982084346709.
  52. Tice Thomas R. (Birmingham AL) Gilley Richard M. (Birmingham AL). Drug delivery system and method of making the same. USP1990014897268.
  53. Slager, Joram; Kurdyumov, Aleksey V.; Swan, Dale G.. Emulsions containing arylboronic acids and medical articles made therefrom. USP2014048709489.
  54. Peyman, Gholam A.. Enhanced ocular neuroprotection and neurostimulation. USP2012068202840.
  55. Peyman, Gholam A.. Enhanced ocular neuroprotection and neurostimulation. USP2010117833966.
  56. Roorda Wouter E. (Newark CA) Ehnow Fred (Mountain View CA). Erosion rate modifier for use in bioerodible drug delivery devices and method of use. USP1996115571525.
  57. Kaplan, Edward J.. Flexible and/or elastic brachytherapy seed or strand. USP2017059636401.
  58. Kaplan, Edward J.. Flexible and/or elastic brachytherapy seed or strand. USP2017059636402.
  59. Kaplan, Edward J.. Flexible and/or elastic brachytherapy seed or strand. USP2014098821835.
  60. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny. Formulations and methods for providing prolonged local anesthesia. USP2000046046187.
  61. Charles B. Berde ; Robert S. Langer ; Joanne Curley ; Jenny Castillo. Formulations and methods for providing prolonged local anesthesia. USP2002076426339.
  62. Chasin Mark ; Sackler Richard ; Burch Ronald M. ; Goldenheim Paul ; Tigner Joseph. Formulations and methods for providing prolonged local anesthesia. USP1999085942241.
  63. Chasin, Mark; Goldenheim, Paul; Sackler, Richard; Tigner, Joseph; Burch, Ronald M. Formulations and methods for providing prolonged local anesthesia. USP2005076921541.
  64. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph. Formulations and methods for providing prolonged local anesthesia. USP2003026521259.
  65. Chasin, Mark; Sackler, Richard; Burch, Ronald M.; Goldenheim, Paul; Tigner, Joseph. Formulations and methods for providing prolonged local anesthesia. USP2003026514516.
  66. Kleinman, David M.; Nivaggioli, Thierry; Gerritsen, Mary E.; Weber, David A.. Formulations and methods for vascular permeability-related diseases or conditions. USP2016099452156.
  67. Kleinman, David M.; Nivaggioli, Thierry; Gerritsen, Mary E.; Weber, David A.. Formulations and methods for vascular permeability-related diseases or conditions. USP2013078486960.
  68. Kleinman, David M.; Nivaggioli, Thierry; Gerritsen, Mary E.; Weber, David A.. Formulations and methods for vascular permeability-related diseases or conditions. USP2012078222271.
  69. Dor, Philippe J. M.; Mudumba, Sreenivasu; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq; Takhar, Sudeep. Formulations for treating ocular diseases and conditions. USP2014038663639.
  70. de Leeuw, Mike; Pierre, Sebastien Jerome. Functionalised triblock copolymers and compositions containing such polymers. USP2015109168221.
  71. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E.. GABA analog prodrug sustained release oral dosage forms. USP2014088795725.
  72. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E.. GABA analog prodrug sustained release oral dosage forms. USP2014128906412.
  73. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny. High load formulations and methods for providing prolonged local anesthesia. USP2001056238702.
  74. Berde Charles B. ; Langer Robert S. ; Curley Joanne ; Castillo Jenny. High load formulations and methods for providing prolonged local anesthesia. USP1999075922340.
  75. Berggren Randall G. (Livermore CA) Enscore David J. (Saratoga CA) Marks Susan M. (San Jose CA) Osborne James L. (Mountain View CA) Wong Patrick S.-L. (Palo Alto CA) Roorda Wouter E. (Newark CA). Injectable drug delivery system and method. USP1997045620700.
  76. Graham Neil B. (6 ; Kilmardinny Grove Bearsden ; Glasgow GB6). Injectable medicinal compositions. USP1979044150108.
  77. Arbogast, Christophe; Bussat, Philippe; Fan, Hong (Helen); Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng. KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. USP2016089408926.
  78. Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng. KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. USP2014018623822.
  79. Sato, Aaron K.; Sexton, Daniel J.; Dransfield, Daniel T.; Ladner, Robert C.; Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Yan, Feng; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.. KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. USP2014028642010.
  80. Sato, Aaron K.; Sexton, Daniel J.; Dransfield, Daniel T.; Ladner, Robert Charles. KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. USP2017049629934.
  81. Sato, Aaron K.; Sexton, Daniel J.; Dransfield, Daniel T.; Ladner, Robert Charles; Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Khurana, Sudha; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng. KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. USP2016099446155.
  82. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q.. Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use. USP2010057709527.
  83. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q.. Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use. USP2012128324272.
  84. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat. Levodopa prodrug mesylate hydrate. USP2013038399513.
  85. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat R.. Levodopa prodrug mesylate hydrate. USP2014058722733.
  86. Xiang, Jia Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q.. Levodopa prodrug mesylate, compositions thereof, and uses thereof. USP2009077563821.
  87. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q.. Levodopa prodrug mesylate, compositions thereof, and uses thereof. USP2012068193242.
  88. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q.. Levodopa prodrug mesylate, compositions thereof, and uses thereof. USP2011067968597.
  89. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q.. Levodopa prodrug mesylate, compositions thereof, and uses thereof. USP2011027893105.
  90. Xiang, Jia Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L.. Levodopa prodrugs, and compositions and uses thereof. USP2009057534813.
  91. Xiang, Jia-Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L.. Levodopa prodrugs, and compositions and uses thereof. USP2010037671089.
  92. Xiang, Jia-Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L.. Levodopa prodrugs, and compositions and uses thereof. USP2012048163958.
  93. Xiang,Jia Ning; Gallop,Mark A.; Zhou,Cindy X.; Nguyen,Mark; Dai,Xuedong; Li,Jianhua; Cundy,Kenneth C.. Levodopa prodrugs, and compositions and uses thereof. USP2008017323585.
  94. Xiang,Jia Ning; Gallop,Mark A.; Zhou,Cindy X.; Nguyen,Mark; Dai,Xuedong; Li,Jianhua; Cundy,Kenneth C.; Jumbe,Nelson L.. Levodopa prodrugs, and compositions and uses thereof. USP2008037342131.
  95. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq. Liquid formulations for treatment of diseases or conditions. USP2016079381153.
  96. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq. Liquid formulations for treatment of diseases or conditions. USP2015018927005.
  97. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq. Liquid formulations for treatment of diseases or conditions. USP2013028367097.
  98. Ottoboni, Thomas B.; Girotti, Lee Ann Lynn. Long-acting polymeric delivery systems. USP2017079694079.
  99. Ottoboni, Thomas B.; Girotti, Lee Ann Lynn. Long-acting polymeric delivery systems. USP2017109801945.
  100. Ottoboni, Thomas B.; Girotti, Lee Ann Lynn. Long-acting polymeric delivery systems. USP20181010098957.
  101. Ottoboni, Thomas B.; Girotti, Lee Ann Lynn. Long-acting polymeric delivery systems. USP20190210213510.
  102. Shen, Hui Rong; Gan, Na. Long-acting semi-solid lipid formulations. USP20190310220093.
  103. Shen, Hui Rong; Gan, Na. Long-acting semi-solid lipid formulations. USP2017129849180.
  104. Kevan Sherrene D.,CAX ; Kevan Peter G.,CAX ; Trevino Jack D.. Medicaments for beneficial insects and method. USP2001126333052.
  105. Grainger David J. (Cambridge GB2) Metcalfe James C. (Cambridge GB2). Method for identifying an agent which increases TGF-beta levels. USP1997015595722.
  106. Frinking, Peter J. A.; Arditi, Marcel. Method for improved measurement of local physical parameters in a fluid-filled cavity. USP2005116962071.
  107. Kozlowski, Antoni. Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid. USP2013058435504.
  108. Kozlowski, Antoni. Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid. USP2012058182801.
  109. Kozlowski, Antoni. Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester. USP2014078784791.
  110. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E.. Method for the management of incontinence. USP2001076262115.
  111. Guittard, George V.; Jao, Francisco; Marks, Susan M.; Kidney, David J.; Gumucio, Fernando E.. Method for the management of incontinence. USP2005076919092.
  112. Janoff Andrew S. (Yardley PA) Cullis Pieter R. (Vancouver CAX) Bally Marcel B. (Vancouver CAX) Fountain Michael W. (Griggstown NJ) Ginsberg Richard S. (Monroe NJ) Hope Michael J. (Vancouver CAX) Madd. Method of dehydrating liposomes using protective sugars. USP1996115578320.
  113. Heller Jorge (Woodside CA) Penhale Donald W. H. (Menlo Park CA) Ng Steve Y. (San Francisco CA). Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product. USP1989084855132.
  114. Ragheb,Anthony O.; Fearnot,Neal E.; Voorhees, III,William D.; Kozma,Thomas G.; Bates,Brian L.; Osborne,Thomas A.. Method of treating a patient with a coated implantable medical device. USP2008117445628.
  115. David J. Grainger GB; Paul R. Kemp GB. Method to determine TGF-.beta.. USP2002056395494.
  116. Grainger,David J.; Kemp,Paul R.. Method to determine TGF-beta. USP2006087094550.
  117. Stanley Theodore H. (Salt Lake City UT) Haque Brian (West Valley City UT). Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics. USP1987064671953.
  118. Stanley Theodore H. (Salt Lake City UT) Hague Brian (West Valley City UT). Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular ac. USP1989124885173.
  119. Kelleher Peter J. (The Woodlands TX). Methods and compositions for the modulation of cell proliferation and wound healing. USP1997045618553.
  120. Kelleher Peter Joseph. Methods and compositions for the modulation of cell proliferation and wound healing. USP2000056063396.
  121. Vargas Rincon, Ricardo Alberto; Reiz, Joseph. Methods and compositions particularly for treatment of attention deficit disorder. USP2018059974752.
  122. Vargas Rincon, Ricardo Alberto; Reiz, Joseph. Methods and compositions particularly for treatment of attention deficit disorder. USP20181010111839.
  123. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.. Methods and devices for providing prolonged drug therapy. USP2014018629179.
  124. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.. Methods and devices for providing prolonged drug therapy. USP2012048163798.
  125. Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.. Methods and devices for providing prolonged drug therapy. USP2015099144549.
  126. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richar. Methods and devices for providing prolonged drug therapy. USP2005086930129.
  127. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richard G.. Methods and devices for providing prolonged drug therapy. USP2015059029416.
  128. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Weyers, Richard G.; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Hatamkhany, Zah. Methods and devices for providing prolonged drug therapy. USP2005076919373.
  129. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D; Hatamkhany, Zahedeh; Weyers, Richard G; Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.. Methods and devices for providing prolonged drug therapy. USP2015049000038.
  130. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F.. Methods and devices for the sustained release of multiple drugs. USP2010117829112.
  131. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F.. Methods and devices for the sustained release of multiple drugs. USP2010117833545.
  132. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F.. Methods and devices for the sustained release of multiple drugs. USP2011027883718.
  133. Ron, Eyal S.; Langer, Robert S.; Crowley, Jr., William F.. Methods and devices for the sustained release of multiple drugs. USP2010117838024.
  134. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri. Methods and dosage forms for controlled delivery of paliperidone and risperidone. USP2016079393192.
  135. Pacetti, Stephen D.; Hossainy, Syed F. A.; Tang, Yiwen; Tung, Andrew C.; Glauser, Thierry. Methods for fabricating coatings for drug delivery devices having gradient of hydration. USP2011118052988.
  136. Pacetti, Stephen D.; Hossainy, Syed F. A.; Tang, Yiwen; Tung, Andrew C.; Glauser, Thierry. Methods for fabricating coatings for drug delivery devices having gradient of hydration. USP2012108277926.
  137. Staas, Jay K.; Tice, Thomas R.; Hudson, Bruce W.; Tipton, Arthur J.. Methods for manufacturing delivery devices and devices thereof. USP2013098541028.
  138. Sackler, Richard S.; Goldenheim, Paul D.; Chasin, Mark; Burch, Ronald M.; Reder, Robert F.; Tigner, Joseph. Methods for providing safe local anesthesia. USP2004036699908.
  139. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A.. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs. USP2007067232924.
  140. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A.. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs. USP2008097423169.
  141. Busetti,Cesare; Crimella,Tiziano. Methods for treating early morning pathologies. USP200608RE39239.
  142. Raillard, Stephen P.; Mann, Adam; Manthati, Suresh K.; Scheuerman, Randall A.; Estrada, Tono; Nguyen, Mark Q.; Zhou, Cindy X. Methods of synthesizing a levodopa ester prodrug. USP2016039290445.
  143. Ng, Steven Y.; Shen, Hui Rong; Heller, Jorge. Methods of treating emesis utilizing semi-solid delivery pharmaceutical compositions comprising granisetron. USP2012088252305.
  144. Ng, Steven Y.; Shen, Hui-Rong; Heller, Jorge. Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron. USP2018039913910.
  145. Kent John S. (Cupertino CA) Lewis Danny H. (Birmingham AL) Sanders Lynda M. (Palo Alto CA) Tice Thomas R. (Birmingham AL). Microencapsulation of water soluble active polypeptides. USP1987064675189.
  146. Kelleher Peter J.. Modulation of cell proliferation and wound healing. USP2000056063116.
  147. Rosenberg, Joerg; Zeidler, Jürgen; Breitenbach, Jörg; Berndl, Gunther; Kleinke, Andreas. Multiphase active ingredient-containing formulations. USP2004096787157.
  148. Arbogast, Christophe; Bussat, Philippe; Fan, Hong; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Pochon, Sibylle; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Yan, Feng; Sato, Aaron K.; Walker, Sharon Michele; Dransfield, Daniel T.. Multivalent constructs for therapeutic and diagnostic applications. USP2014038663603.
  149. Fan, Hong; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Sato, Aaron K.; Walker, Sharon Michele; Dransfield, Daniel T.. Multivalent constructs for therapeutic and diagnostic applications. USP2015069056138.
  150. Fan, Hong; Linder, Karen E.; Marinelli, Edmund R.; Nanjappan, Palaniappa; Nunn, Adrian D.; Pillai, Radhakrishna K.; Ramalingam, Kondareddiar; Shrivastava, Ajay; Song, Bo; Swenson, Rolf E.; Von Wronski, Mathew A.; Sato, Aaron K.; Walker, Sharon Michele; Dransfield, Daniel T.. Multivalent constructs for therapeutic and diagnostic applications. USP2014018632753.
  151. Mathiowitz, Edith; Jacob, Jules S.; Chickering, III, Donald E.; Leach, Kathleen Jo. Multiwall polymeric microcapsules from hydrophilic polymers. USP2003036528035.
  152. Ahlers Michael (Mainz DEX) Walch Axel (Frankfurt am Main DEX) Seipke Gerhard (Hofheim DEX) Russell-Jones Gregory (Middel Cove AUX). Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and us. USP1997105674531.
  153. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2014098846648.
  154. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2015038987237.
  155. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2014098846649.
  156. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2015049012434.
  157. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2015038987238.
  158. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2015018933059.
  159. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2015049006222.
  160. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2014018633178.
  161. Bernick, Brian A.; Cacace, Janice Louise; Persicaner, Peter H. R.; Irani, Neda; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP2016049301920.
  162. Bernick, Brian A.; Persicaner, Peter H. R.; Amadio, Julia M.. Natural combination hormone replacement formulations and therapies. USP20190210206932.
  163. Stanley Theodore H. ; Hague Brian. Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient. USP1999015855908.
  164. Dunn Richard L.. Non-polymeric sustained release delivery system. USP2000096120789.
  165. Dunn Richard L.. Non-polymeric sustained release delivery system. USP1998045736152.
  166. Dunn Richard L.. Non-polymeric sustained release delivery system. USP1999035888533.
  167. de Juan, Jr., Eugene; Alster, Yair; Reich, Cary J.; MacFarlane, K. Angela; Chang, Janelle; Alejandro, Jose D.. Ocular insert apparatus and methods. USP2014058715712.
  168. de Juan, Jr., Eugene; Alster, Yair; Reich, Cary J.; MacFarlane, K. Angela; Chang, Janelle; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Sutton, Douglas; Gould, Alexander J.. Ocular insert apparatus and methods. USP2015018939948.
  169. de Juan, Jr., Eugene; Alster, Yair; Reich, Cary J.; Macfarlane, K. Angela; Chang, Janelle; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Sutton, Douglas; Gould, Alexander J.. Ocular insert apparatus and methods. USP2018049937073.
  170. Peyman,Gholam. Ocular solutions. USP2006087087237.
  171. Peyman,Gholam. Ocular solutions. USP2006087083803.
  172. Rubin, Anne Brody; Alster, Yair; Reich, Cary J.. Ophthalmic system for sustained release of drug to eye. USP2017099750636.
  173. Cundy, Kenneth C.; Gallop, Mark A.. Orally administered dosage forms of GABA analog prodrugs having reduced toxicity. USP2004126833140.
  174. Zentner Gaylen M. (Lawrence KS) Himmelstein Kenneth J. (Irvine CA) Pogany Stefano A. (Lawrence KS) Ringeisen Cheryl (Olathe KS). Organic acids as catalysts for the erosion of polymers. USP1988104780319.
  175. Heller Jorge (Woodside CA) Ng Steve Y. W. (San Francisco CA) Penhale Donald W. H. (Menlo Park CA). Ortho and thio-ortho ester polymer. USP1991055013821.
  176. Kozlowski, Antoni. Orthoester compound. USP2015069045494.
  177. Schmitt Edward E. (Palo Alto CA). Pharmaceutical composition of poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having. USP1979054155992.
  178. Mao, Chen; Pargaonkar, Nikhil; Maurer, Laura E.; Ma, Sarina Grace Harris. Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use. USP2013058435562.
  179. Robert Gurny CH; Monia Zignani CH; Cyrus Tabatabay CH. Pharmaceutical compositions containing buffered ortho ester polymers. USP2002086440460.
  180. Pierre, Sebastien Jerome; De Leeuw, Mike. Pharmaceutical compositions containing functionalized triblock copolymers. USP2016069364544.
  181. Ng, Steven Y.; Shen, Hui-Rong; Heller, Jorge. Pharmaceutical compositions using semi-solid delivery vehicle. USP2005036861068.
  182. Ng, Steven Y.; Shen, Hui-Rong; Heller, Jorge. Pharmaceutical compositions using semi-solid delivery vehicle. USP2004096790458.
  183. Choi Nam S. (Seoul KRX). Pharmaceutical comprising drug and polymer. USP1981084282201.
  184. Malcolm, Karl; Woolfson, David; Romano, Joseph. Platinum-catalyzed intravaginal rings. USP2016089427400.
  185. Malcolm, Karl; Woolfson, David; Romano, Joseph. Platinum-catalyzed intravaginal rings. USP2013118580294.
  186. Gao,Qingzhi; Gallop,Mark A.; Xiang,Jia Ning. Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use. USP2007047208611.
  187. Alkatout, Julie A.; Benz, Michael Eric; Sparer, Randall V.. Poly(orthoester) polymers, and methods of making and using same. USP2011017875697.
  188. Alkatout, Julie A.; Benz, Michael Eric; Sparer, Randall V.. Poly(orthoester) polymers, and methods of making and using same. USP2012038133968.
  189. Choi Nam S. (Seoul KPX). Polymers comprising heterocyclic system. USP1981014246397.
  190. Heller Jorge (Woodside CA) Ng Steve Y. W. (San Francisco CA) Penhale Donald W. H. (Menlo Park CA). Polymers containing acetal, carboxy-acetal, ortho ester and carboxyortho ester linkages. USP1990094957998.
  191. Heller Jorge (Woodside CA). Polymers containing pendant acid functionalities and labile backbone bonds. USP1987014639366.
  192. Heller Jorge ; Ng Steven Y.. Polymers with controlled physical state and bioerodibility. USP1999105968543.
  193. Jenkins, Thomas E.. Polysubunit opioid prodrugs resistant to overdose and abuse. USP2017119808452.
  194. Jenkins, Thomas E.. Polysubunit opioid prodrugs resistant to overdose and abuse. USP20190410251878.
  195. Sudmann Einar (Os CA NOX) Bonsen Pieter (Los Altos CA) Lee Eun S. (Redwood City CA). Post-surgical applications for bioerodible polymers. USP1990044913903.
  196. Mathiowitz Edith ; Jacob Jules S. ; Chickering ; III Donald E. ; Pekarek Kathleen Jo. Preparation of multiwall polymeric microcapsules from hydrophilic polymers. USP1999115985354.
  197. Mathiowitz, Edith; Jacob, Jules S.; Chickering, III, Donald E.; Pekarek, Kathleen Jo. Preparation of multiwall polymeric microcapsules from hydrophilic polymers. USP2003016511749.
  198. Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Kunz Lawrence L. ; Schroff Robert W. ; Weissberg Peter L.,GB2. Prevention and treatment of cardiovascular pathologies. USP1998065770609.
  199. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Kunz Lawrence L. ; Schroff Robert W. ; Weissberg Peter L.,GBX. Prevention and treatment of cardiovascular pathologies. USP2001076262079.
  200. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX. Prevention and treatment of cardiovascular pathologies. USP2001066251920.
  201. Grainger David J.,GBX ; Metcalfe James C.,GBX ; Kunz Lawrence L. ; Schroff Robert W.. Prevention and treatment of cardiovascular pathologies with tamoxifen analogues. USP2001036197789.
  202. Ng, Steven Y.; Shen, Hui Rong; Heller, Jorge. Process for preparing a semi-solid delivery vehicle comprising granisetron. USP2012088252306.
  203. Biggs, Danielle; Nettles, Heather. Process for preparing microparticles having a low residual solvent volume. USP2014058728528.
  204. Gallop, Mark A.. Prodrugs of gaba analogs, compositions and uses thereof. USP2016019238616.
  205. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D.. Progesterone formulations. USP20180810052386.
  206. Goldenheim Paul ; Lacouture Peter ; Donigi-Gale Donna ; Chasin Mark ; Sackler Richard. Prolonged anesthesia in joints and body spaces. USP2001066248345.
  207. Goldenheim, Paul; Donigi-Gale, Donna; Sackler, Richard; Lacouture, Peter; Chasin, Mark. Prolonged anesthesia in joints and body spaces. USP2003036534081.
  208. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq. Rapamycin formulations and methods of their use. USP2016079387165.
  209. Mudumba, Sreenivasu; Dor, Philippe J M; Nivaggioli, Thierry; Weber, David A.; Farooq, Sidiq. Rapamycin formulations and methods of their use. USP2014018637070.
  210. Ng, Steven Y.; Shen, Hui-Rong; Heller, Jorge. Semi-solid delivery vehicle and pharmaceutical compositions. USP2003096613355.
  211. Ng, Steven Y.; Shen, Hui Rong; Heller, Jorge. Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron. USP2012088252304.
  212. Ng, Steven Y.; Shen, Hui Rong; Heller, Jorge. Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron. USP2014058715710.
  213. Chen, Guohua; Priebe, David T.. Short duration depot formulations. USP20190210201496.
  214. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Irani, Neda; Cacace, Janice Louise; Thorsteinsson, Thorsteinn; Sancilio, Frederick D.. Soluble estradiol capsule for vaginal insertion. USP2015119180091.
  215. Sutton Andrew D.,GBX ; Johnson Richard A.,GBX ; Senior Peter J.,GBX ; Heath David,GBX. Spray-dried microparticles and their use as therapeutic vehicles. USP1999115993805.
  216. Sutton, Andrew D.; Johnson, Richard A.; Senior, Peter J.; Heath, David. Spray-dried microparticles and their use as therapeutic vehicles. USP2004036709650.
  217. Mudumba, Sreenivasu; Nivaggioli, Thierry; Takhar, Sudeep Kaur. Stable formulations, and methods of their preparation and use. USP2013078492400.
  218. Mudumba, Sreenivasu; Nivaggioli, Thierry; Takhar, Sudeep Kaur. Stable formulations, and methods of their preparation and use. USP2014028658667.
  219. Alt, Eckhard. Stent device and method. USP2009127625410.
  220. Shadiack, Annette; Persicaner, Peter H. R.; Inskeep, Philip B.; Thorsteinsson, Thorsteinn; Sancilio, Frederick D.; Legassie, Jason D.. Steroid hormone pharmaceutical composition. USP2018049931349.
  221. Choi ; Nam S. ; Heller ; Jorge. Structured orthoester and orthocarbonate drug delivery devices. USP1978124131648.
  222. Maskiewicz, Richard. Sublimable sustained release delivery system and method of making same. USP2016049301919.
  223. Maskiewicz, Richard. Sublimable sustained release delivery system and method of making same. USP2015038987340.
  224. Silvestri Loui J. (Miramar FL) Pyle H. Ruth (Ft. Lauderdale FL). Sustained release dosage form. USP1991024990336.
  225. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2017049622983.
  226. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2017019549940.
  227. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2014118877248.
  228. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2015038992989.
  229. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2014038663683.
  230. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2017019555004.
  231. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2012108298580.
  232. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2014118889191.
  233. Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L.. Sustained-release formulations of topiramate. USP2012108298576.
  234. Jao Frank ; Wong Patrick S.-L. ; Huynh Hoa T. ; Mc Chesney Kathy ; Wat Pamela K.. System for delaying drug delivery up to seven hours. USP2000116146662.
  235. Jao, Frank; Wong, Patrick S. -L.; Huynh, Hoa T.; Mc Chesney, Kathy; Wat, Pamela K.. System for delaying drug delivery up to seven hours. USP2004076764697.
  236. Covannon, Edward; Squilla, John R.; Rankin Parobek, Donna K.; Rinas, Eugene R.; Blish, Nelson A.. System to monitor the ingestion of medicines. USP2009117616111.
  237. Covannon, Edward; Squilla, John R.; Rankin-Parobek, Donna K.; Rinas, Eugene R.; Blish, Nelson A.. System to monitor the ingestion of medicines. USP2015069058530.
  238. Covannon, Edward; Squilla, John R.; Rankin-Parobek, Donna K.; Rinas, Eugene R.; Blish, Nelson A.. System to monitor the ingestion of medicines. USP2013108564432.
  239. Covannon, Edward; Squilla, John R.; Rankin-Parobek, Donna K.; Rinas, Eugene R.; Blish, Nelson A.. System to monitor the ingestion of medicines. USP2015119183724.
  240. Covannon, Edward; Squilla, John R.; Rankin-Parobek, Donna K.; Rinas, Eugene R.; Blish, Nelson A.. System to monitor the ingestion of medicines. USP2017059659476.
  241. Spoonhower, John P.; Covannon, Edward. System to monitor the ingestion of medicines. USP2010087782189.
  242. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna K.; Pochon, Sibylle; Song, Bo; Swenson, Rolf E.. Targeting vector-phospholipid conjugates. USP2016039295737.
  243. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna K.; Pochon, Sibylle; Song, Bo; Swenson, Rolf E.. Targeting vector-phospholipid conjugates. USP2016079381258.
  244. Bussat, Philippe; Cherkaoui, Samir; Fan, Hong (Helen); Lamy, Bernard; Nanjappan, Palaniappa; Pillai, Radhakrishna; Pochon, Sibylle; Song, Bo; Swenson, Rolf E.. Targeting vector-phospholipid conjugates. USP2013108551450.
  245. Kunz Lawrence L.. Therapeutic inhibitor of vascular smooth muscle cells. USP2001076268390.
  246. Kunz Lawrence L.. Therapeutic inhibitor of vascular smooth muscle cells. USP2001016171609.
  247. Kunz Lawrence L. ; Klein Richard A. ; Reno John M.. Therapeutic inhibitor of vascular smooth muscle cells. USP1999115981568.
  248. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GB2 ; Metcalfe James C.,GB2 ; Weissberg Peter L.,GB2 ; Anderson Peter G.. Therapeutic inhibitor of vascular smooth muscle cells. USP1998095811447.
  249. Kunz Lawrence L. ; Klein Richard A. ; Reno John M. ; Grainger David J.,GBX ; Metcalfe James C.,GBX ; Weissberg Peter L.,GBX ; Anderson Peter G.. Therapeutic inhibitor of vascular smooth muscle cells. USP2000066074659.
  250. Kunz Lawrence L. ; Reno John M.. Therapeutic inhibitor of vascular smooth muscle cells. USP2001106306421.
  251. Kunz, Lawrence L.; Anderson, Peter G.. Therapeutic inhibitor of vascular smooth muscle cells. USP2011118067022.
  252. Kunz, Lawrence L.; Anderson, Peter G.. Therapeutic inhibitor of vascular smooth muscle cells. USP2012048158670.
  253. Kunz, Lawrence L.; Anderson, Peter G.. Therapeutic inhibitor of vascular smooth muscle cells. USP2012018097642.
  254. Kunz, Lawrence L.; Klein, Richard A.. Therapeutic inhibitor of vascular smooth muscle cells. USP2003026515009.
  255. Kunz, Lawrence L.; Klein, Richard A.. Therapeutic inhibitor of vascular smooth muscle cells. USP2003076599928.
  256. Kunz, Lawrence L.; Klein, Richard A.; Reno, John M.. Therapeutic inhibitor of vascular smooth muscle cells. USP2004046720350.
  257. Kunz, Lawrence L.; Reno, John M.. Therapeutic inhibitor of vascular smooth muscle cells. USP2003126663881.
  258. Kunz, Lawrence L.; Reno, John M.. Therapeutic inhibitor of vascular smooth muscle cells. USP2003056569441.
  259. Lawrence L. Kunz ; John M. Reno. Therapeutic inhibitor of vascular smooth muscle cells. USP2002126491938.
  260. Lawrence L. Kunz ; Richard A. Klein ; John M. Reno. Therapeutic inhibitor of vascular smooth muscle cells. USP2002036358989.
  261. Nangia, Avinash; Verma, Daya D.; Jacob, Jules. Topiramate compositions and methods of enhancing its bioavailability. USP2017089744137.
  262. Bernick, Brian A.; Amadio, Julia M.; Persicaner, Peter H. R.; Cacace, Janice Louise; Irani, Neda; Sancilio, Frederick D.. Transdermal hormone replacement therapies. USP2016029248136.
  263. Cooper, Eugene R.; Kleinman, David M.; Nivaggioli, Thierry; Dor, Philippe J M; Mudumba, Sreenivasu. Transscleral delivery. USP2009097585517.
  264. Barrett, Ronald W.; Canafax, Daniel M.. Treating or preventing restless legs syndrome using prodrugs of GABA analogs. USP2012028114909.
  265. Barrett, Ronald W.. Treating urinary incontinence using prodrugs of GABA analogs. USP2010047700652.
  266. Peyman,Gholam. Treatment of ocular disease. USP2006087083802.
  267. Peyman,Gholam A.. Treatment of ocular disease. USP2008047354574.
  268. Swiss, Gerald F.; Rao, Photon; Sabnis, Ram W.. Trisubstituted methyl alcohols and their polymerizable derivatives. USP2015089115066.
  269. Ayer, Atul D.; Lam, Andrew; Magruder, Judy A.; Hamel, Lawrence G.; Wong, Patrick S. L.. Uniform drug delivery therapy. USP2003036534089.
  270. Bernick, Brian A.; Amadio, Julia M.. Vaginal inserted estradiol pharmaceutical compositions and methods. USP2016039289382.
  271. Mirkin, Sebastian; Amadio, Julia M.; Bernick, Brian A.. Vaginal inserted estradiol pharmaceutical compositions and methods. USP20190410258630.
  272. Asgharian, Bahram; Chowhan, Masood A.; Wax, Martin B.. Water insoluble polymer matrix for drug delivery. USP2014018632809.
  273. Vaghefi, Farid; Lee, Jeffry; Nalamothu, Vijendra. Zero order release and temperature-controlled microcapsules and process for the preparation thereof. USP2003046544646.
  274. Auf Der Maur, Adrian; Barberis, Alcide; Urech, David M.; Lichtlen, Peter. scFv antibodies which pass epithelial and/or endothelial layers. USP2015018936785.

IPC 상위 출원인